Pilot of asymptomatic swabbing of humans following exposures to confirmed avian influenza A(H5) in avian species in England, 2021/2022.


Journal

Influenza and other respiratory viruses
ISSN: 1750-2659
Titre abrégé: Influenza Other Respir Viruses
Pays: England
ID NLM: 101304007

Informations de publication

Date de publication:
08 2023
Historique:
received: 01 02 2023
revised: 07 06 2023
accepted: 07 08 2023
medline: 29 8 2023
pubmed: 28 8 2023
entrez: 28 8 2023
Statut: epublish

Résumé

A programme of asymptomatic swabbing was piloted in 2021/2022 in England to further understand the risk of human infection with avian influenza in exposed individuals and to evaluate this surveillance approach as a public health measure. There were challenges in deploying this pilot that will need to be addressed for future seasons. However, there was one detection of avian influenza A(H5N1) in a human despite low uptake in eligible exposed persons. Future use of asymptomatic swabbing could help provide an evidence base to quantify asymptomatic infection, quickly identify signals of increased animal to human transmission and improve public health preparedness.

Identifiants

pubmed: 37638093
doi: 10.1111/irv.13187
pii: IRV13187
pmc: PMC10447230
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13187

Informations de copyright

© 2023 Crown copyright. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd. This article is published with the permission of the Controller of HMSO and the King's Printer for Scotland.

Déclaration de conflit d'intérêts

No authors declare any conflicts of interest.

Références

Lancet. 1998 Feb 14;351(9101):467-71
pubmed: 9482437
Euro Surveill. 2022 Feb;27(5):
pubmed: 35115075
J Infect Dis. 2020 Jul 23;222(4):528-537
pubmed: 32157291
J Infect Dis. 2019 Jun 5;220(1):20-22
pubmed: 30788504
One Health. 2022 Apr 27;14:100392
pubmed: 35686147
Euro Surveill. 2021 Jun;26(24):
pubmed: 34142650
mBio. 2022 Aug 30;13(4):e0060922
pubmed: 35726917

Auteurs

Fernando Capelastegui (F)

UK Health Security Agency London UK.

Julianna Smith (J)

UK Health Security Agency London UK.

Jharna Kumbang (J)

UK Health Security Agency London UK.

Clare Humphreys (C)

UK Health Security Agency London UK.

Simon Padfield (S)

UK Health Security Agency London UK.

Jonathan Turner (J)

UK Health Security Agency London UK.

Andrew Mumford (A)

UK Health Security Agency London UK.

Nick Richardson (N)

UK Health Security Agency London UK.

Isabel Oliver (I)

UK Health Security Agency London UK.

Gavin Dabrera (G)

UK Health Security Agency London UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH